Silent ischaemia in familial hypercholesterolemia

Area of Science:

• Cardiology
• Genetics
• Preventive Medicine

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder leading to high LDL cholesterol and premature cardiovascular disease.
• Early detection and management of coronary heart disease (CHD) in FH patients are critical for preventing adverse outcomes.

Discussion:

• A significant proportion of FH men aged 25-55 exhibit signs of coronary heart disease, including symptomatic and asymptomatic myocardial ischemia.
• Asymptomatic myocardial ischemia in FH men is frequently associated with severe coronary artery stenosis, necessitating intervention.
• Exercise stress testing identified significant ST/T changes in 20% of FH men, with 75% of those undergoing angiography showing severe disease.

Key Insights:

• The incidence of coronary heart disease in this FH cohort was 52%, with 32% having a history of symptomatic disease.
• Even silent myocardial ischemia in FH men is linked to severe coronary artery disease, requiring prompt attention.
• Coronary angioplasty or bypass surgery was performed on 4 out of 6 patients with severe stenosis identified via exercise stress testing.

Outlook:

• Systematic exercise testing should be implemented for all asymptomatic FH men over the age of 25.
• Further research should explore long-term outcomes and optimal screening strategies for FH populations.
• Integrating genetic screening with cardiovascular risk assessment can improve early diagnosis and treatment of FH.